Asset 1@4x 4

KNOWLEDGE IS A TREASURE TO SHARE

Clinical Trial Support Platforms for Phase 4 Studies

Problem description In the later phases of clinical trials (Phase 4), pharmaceutical companies require platforms to manage patient data, eligibility criteria, and the dissemination of results. The platforms must also support continuous patient  monitoring and treatment tracking throughout the trial. Project objective The main goal was to develop

Brussels Tunnels – Web application & Project

Project scope Smoother traffic, improved user safety, less gas emission. The city of tomorrow is connected, sustainable and safe. Throughout the year, Brussels Mobility inspects the condition of the capital's tunnels. Based on these diagnoses, the administration schedules in depth maintenance work.The client turned to Atracore

Complex Tourism Platform Development for JEKA

JEKA operates a unique business model, distinct from traditional travel agencies, which required a custom platform to manage all their operations. This included the integration of accounting systems, calendars, and compliance with the diverse legislation across Western Europe. Project objective The goal was to develop a comprehensive

Leveraging CLEVAIR-HTA’s AI Capabilities

for Custom AI Integration Beyond the Pharmaceutical Industry EXECUTIVE SUMMARY CLEVAIR-HTA is a powerful AI-driven platform originally designed for Health Technology Assessment (HTA) in the pharmaceutical and medical device industries. However, its technical architecture, automation capabilities, and AI powered analytics are highly adaptable, making it an ideal

Anticancer Fund

The Anticancer Fund (ACF), a Belgian non-profit organization, sought to improve the management of patient requests for scientific advice through its My Cancer Navigator (MCN) service. To achieve this, Atracore developed a centralized electronic platform that streamlines the collection of patient medical information and scientific

Genetic new-born screening in FWB

The CHU of Liège, a major academic hospital in Wallonia, partnered with Atracore to develop a secure application for transferring patient consent information to a genetic laboratory. This initiative aimed to facilitate a study screening newborns for over 120 treatable but currently unscreened genetic diseases.